51. Transferrin- and albumin-directed expression of growth-related peptides in transgenic sheep.
- Author
-
Rexroad CE Jr, Mayo K, Bolt DJ, Elsasser TH, Miller KF, Behringer RR, Palmiter RD, and Brinster RL
- Subjects
- Animals, Animals, Genetically Modified growth & development, Animals, Genetically Modified metabolism, Blood Glucose analysis, Blotting, Northern, Diabetes Mellitus genetics, Diabetes Mellitus veterinary, Female, Gene Expression Regulation, Growth Hormone biosynthesis, Growth Hormone-Releasing Hormone biosynthesis, Growth Hormone-Releasing Hormone genetics, Insulin blood, Male, Microinjections veterinary, RNA analysis, Sheep growth & development, Sheep metabolism, Sheep Diseases genetics, Albumins genetics, Animals, Genetically Modified genetics, Growth Hormone genetics, Sheep genetics, Transferrin genetics
- Abstract
Chimeric genes containing either the mouse transferrin (Trf) enhancer/promoter fused to the structural sequences encoding bovine growth hormone (GH) or the mouse albumin (Alb) enhancer/promoter fused to the gene for human growth hormone-releasing factor (GRF) were microinjected into sheep zygotes. A low percentage of resulting transgenic sheep chronically expressed the respective genes, resulting in elevated plasma concentrations of circulating GH or GRF, respectively. Growth hormone-releasing factor expression induced elevated plasma levels of endogenous GH production. In addition, elevated levels of circulating insulin-like growth factor-I were observed in the bovine GH-expressing Trf transgenic sheep. Growth of these founder transgenic sheep relative to controls were not enhanced. In part, this may be due to the development of the diabetic condition exhibited by both transgenic groups. These results demonstrate that the mouse Trf and Alb enhancer/promoters are active in sheep and suggest that alternate strategies for expressing growth-related genes may be required to modulate growth in sheep.
- Published
- 1991
- Full Text
- View/download PDF